HLA variations in patients with diffuse large B-cell lymphoma and association with disease risk and prognosis: a case-control study.

3.4 Notable differences in HLA allele frequency between DLBCL patients and controls that did not reach statistical significance The alleles that slightly differed between DLBCL patients and controls were HLA-Α*01 (9.15% [controls] vs. 4.17% [patients], p = 0.09, OR = 0.43, 95% CI [0.13–1.12]), HLA-Α*33 (1.49% [controls] vs. 4.17% [patients], p = 0.08, OR = 2.87, 95% CI [0.7–10.72]), HLA-Β*27 (2.79% [controls] vs. 0% [patien

also in 111,027 other papers